Cellosaurus logo
expasy logo

Cellosaurus NCC-ESOS1-C1 (CVCL_YD21)

[Text][XML][JSON]
Cell line name NCC-ESOS1-C1
Accession CVCL_YD21
Resource Identification Initiative To cite this cell line use: NCC-ESOS1-C1 (RRID:CVCL_YD21)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Characteristics: Exhibits invasion capability (PubMed=31625124).
Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
Doubling time: ~40 hours (PubMed=31625124); ~24 hours (DOI=10.2198/jelectroph.65.1).
Omics: Phenotyping; Drug screening.
Derived from site: Metastatic; Forearm, hypodermis; UBERON=UBERON_0002386+UBERON_0002072.
Sequence variations
Disease Extraskeletal osteosarcoma (NCIt: C8810)
Osteosarcoma (ORDO: Orphanet_668)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 58Y
Category Cancer cell line
STR profile Source(s): PubMed=31625124

Markers:
AmelogeninX
CSF1PO12
D5S81811,12,13
D7S82010,12
D13S31711,13
D16S5399,10
D21S1129,32
TH018,9
TPOX8
vWA14,18

Run an STR similarity search on this cell line
Publications

PubMed=31625124; DOI=10.1007/s13577-019-00291-z
Fusako Kito, Rieko Oyama, Rei Noguchi, Emi Hattori, Marimu Sakumoto, Makoto Endo, Eisuke Kobayashi, Akihiko Yoshida, Akira Kawai, Tadashi Kondo;
Establishment and characterization of novel patient-derived extraskeletal osteosarcoma cell line NCC-ESOS1-C1.
Hum. Cell 33:283-290(2020)

DOI=10.2198/jelectroph.65.1
Rei Noguchi, Yuki Yoshimatsu, Takuya Ono, Akane Sei, Tadashi Kondo;
Proteogenomic approach to drug targets in osteosarcomas with different original sites.
J. Electroph. 65:1-11(2021)

Cross-references
Cell line databases/resources cancercelllines; CVCL_YD21
Encyclopedic resources Wikidata; Q95992527
Entry history
Entry creation19-Dec-2019
Last entry update27-Nov-2025
Version number14